AkiraBio
1 known investors
Akira Bio develops therapies for people living with sickle cell disease and other hemoglobinopathies. It is a biotechnology company focused on treatments for blood disorders.
Investors · 1
Frequently asked questions
- What does AkiraBio do?
- Akira Bio develops therapies for people living with sickle cell disease and other hemoglobinopathies. It is a biotechnology company focused on treatments for blood disorders.
- Who are AkiraBio's investors?
- AkiraBio's investors include Vivo Capital.